Should I Buy PDRX Stock in 2026?
Data-driven analysis and honest assessment for Pd-Rx Pharmaceutical
Current Price: $3.35P/E: 3.1
Decision Score
Weak
Based on 6 fundamental factors
Score Breakdown:
Very low P/E of 3.1 suggests undervaluation
Slow growth of 0%
Currently unprofitable
Financial health data limited
Negative free cash flow
No recent insider activity
Key Investment Metrics
Current Price
$3.35
P/E Ratio
3.10
Revenue Growth
-0.0%
Profit Margin
-0.0%
Market Cap
$0.0B
Dividend Yield
None
How PDRX Compares to Competitors
Understanding how PDRX stacks up against peers helps inform your investment decision.
How PDRX Compares to Peers
Upcoming Events for PDRX
+5 Reasons TO Buy PDRX
1. Attractively valued at 3.1x earnings
strongA P/E ratio of 3.1 is below the market average of ~20x, suggesting the stock may be undervalued.
-5 Reasons NOT to Buy PDRX
1. Negative free cash flow
high riskBurning cash creates funding risk and limits shareholder returns.
2. Small-cap volatility risk
high riskMarket cap under $2B means higher volatility and lower liquidity.
3. Revenue declining 0%
medium riskShrinking revenue suggests loss of market share or weakening demand. Turnarounds are difficult.
4. Low gross margins of 30%
medium riskMargins below 30% indicate commodity-like pricing and input cost vulnerability.
Who Should Buy PDRX?
Investment Profile
Risk Level
Very High
Recommended Holding Period
5+ years (turnaround required)
Best For:
Not Suitable For:
- ✗
Growth Investors
Limited -0% growth may disappoint
- ✗
Income-Focused Retirees
No dividend paid
- ✗
Risk-Averse Investors
Very High risk may cause uncomfortable volatility
- ✗
Large Position Traders
Lower liquidity may impact execution
Consider These Alternatives
If you're interested in PDRX, compare these Healthcare peers:
Pro tip: Compare PDRX directly with competitors using our comparison tool to see which stock better fits your criteria.
Get the Full Picture
Access AI-powered insights, DCF valuations, insider trading data, and real-time analysis for PDRX
Frequently Asked Questions
What is PDRX stock price today?
PDRX (Pd-Rx Pharmaceutical) stock is trading at $3.35 as of the latest market data. Stock prices update in real-time during market hours (9:30 AM - 4:00 PM ET).
Is PDRX stock going up or down today?
PDRX stock price movements are influenced by market conditions, news, earnings reports, and investor sentiment. Check our live dashboard for real-time price changes and technical indicators.
Should I buy PDRX stock now?
The decision to buy PDRX depends on your investment strategy, risk tolerance, and financial goals. Our AI analysis evaluates fundamentals, valuation metrics, growth prospects, and market conditions to help inform your decision.
Is PDRX a buy, hold, or sell right now?
Our AI-powered analysis provides buy/hold/sell recommendations for PDRX based on multiple factors including valuation, growth metrics, technical indicators, and analyst consensus. Visit our dashboard for the latest recommendation.
Is PDRX stock overvalued or undervalued?
PDRX currently trades at a P/E ratio of 3.10, which may suggest attractive valuation. Our DCF calculator provides intrinsic value estimates to help determine if PDRX is fairly priced.
What is PDRX's P/E ratio?
PDRX has a price-to-earnings (P/E) ratio of 3.10, which measures how much investors are willing to pay per dollar of earnings. Compare this to industry peers and historical averages for context.
What is PDRX's market cap?
PDRX (Pd-Rx Pharmaceutical) has a market capitalization of $0.01 billion, making it a small-cap stock.
What is PDRX's price to book ratio?
Price-to-book ratio for PDRX is available on our dashboard along with other valuation metrics.
Deep Dive Analysis
Explore comprehensive analysis tools to make an informed decision about Pd-Rx Pharmaceutical
Full Stock Analysis
Complete PDRX overview with charts and data
Is PDRX Undervalued?
DCF valuation and intrinsic value analysis
Dividend Analysis
Yield, payout ratio, and dividend history
Growth Analysis
Revenue, earnings, and expansion metrics
Financial Health
Debt, liquidity, and balance sheet strength
Price Prediction
2026 forecast and price targets
Stock Forecast
12-month price forecast and analyst targets
Earnings Date
Next earnings date and historical results
Compare Before You Buy
See how PDRX stacks up against its competitors
Similar Investment Decisions
Explore investment analyses for stocks similar to Pd-Rx Pharmaceutical
Complete PDRX Analysis
Compare PDRX With
Disclaimer
This analysis is for informational purposes only and should not be considered financial advice. The decision score and recommendations are based on quantitative factors and do not account for all risks, your personal financial situation, or qualitative factors. Always do your own research and consider consulting with a financial advisor before making investment decisions.